Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Exercise-based cardiac rehabilitation program
- Registration Number
- NCT01432639
- Lead Sponsor
- Universidade do Porto
- Brief Summary
The main purposes of this study is to analyze, in a randomized controlled trial, the effects of an exercise-based cardiac rehabilitation program (i) on biomarkers of endothelial function, (ii) on biomarkers of inflammation, (iii) on autonomic function, and (iv) on arterial stiffness in coronary artery disease patients (CAD). Additionally, the investigators aim to analyze the (v) contribution of age and the changes in traditional risk factors to the modification of the endothelial dysfunction and inflammation, and (vi) the contribution of the changes in inflammatory and endothelial function biomarkers to the modification of autonomic function and arterial stiffness.
The investigators hypothesize that exercise training will improve the autonomic function, arterial stiffness and mitigate the endothelial dysfunction and inflammation in CAD patients even in the absence of significant changes in traditional risk factors. Thus, the investigators expect with the present study to promote, develop and expand the knowledge in this field by assessing the impact of exercise on a pool of markers that provide a wide picture of the pathophysiological processes underlying CAD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 96
- acute myocardial infarction
- ventricular tachyarrhythmia
- uncontrolled hypertension (systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg)
- significant valvular disease
- unstable angina pectoris
- reduced left ventricular function (ejection fraction < 45%)
- abnormal hemodynamic response
- myocardial ischemia and/or severe ventricular arrhythmias during baseline exercise testing
- uncontrolled metabolic disease (e.g. uncontrolled diabetes or thyroid disease)
- presence of pulmonary and renal co-morbidities
- peripheral artery disease and/or orthopedic limitations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental group Exercise-based cardiac rehabilitation program Patients undergoing the exercise-based cardiac rehabilitation program (intervention)
- Primary Outcome Measures
Name Time Method Autonomic Function Change from Baseline in Autonomic Function at 8 weeks of Cardiac Rehabilitation Program Autonomic function will be assessed by resting heart rate variability, heart rate recovery after maximal exercise and circulating levels of norepinephrine and epinephrine.
- Secondary Outcome Measures
Name Time Method Arterial Stiffness Change from Baseline in Arterial Stiffness at 8 weeks of Cardiac Rehabilitation Program Arterial Stiffness will be assessed by carotid-femoral pulse wave velocity and the aortic augmentation index.
Endothelial Function Change from Baseline in Endothelial Function at 8 weeks of Cardiac Rehabilitation Program Using commercially available assay kits (R\&D Systems, Minneapolis, MN, USA), the serum levels of sICAM-1 and sVCAM-1 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Cardiorespiratory Fitness Change from Baseline in Cardiorespiratory Fitness at 8 weeks of Cardiac Rehabilitation Program Maximal or symptom-limited treadmill exercise testing will be conducted using the modified Bruce protocol.
Inflammatory Biomarkers Change from Baseline in Inflammatory Biomarkers at 8 weeks of Cardiac Rehabilitation Program Using commercially available assay kits (R\&D Systems, Minneapolis, MN, USA), the serum levels of CRP, IL-10 and IL-6 will be measured in serum by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions and read at 450 nm using a microplate reader (Labsystems iEMS MF controlled by Ascent software v. 2.4, Dynex Labsystems).
Anthropometrics Change from Baseline in Anthropometrics at 8 weeks of Cardiac Rehabilitation Program Height and weight measurements will be assessed using a standard wall-mounted stadiometer and portable digital beam scale (SECA, 708), respectively. Body mass index will be calculated from the ratio of weight (kg) to squared height (m2). Percentage of fat mass will be estimated by bioelectrical impedance analysis (BC-532, Tanita, Tokyo, Japan).
Blood Pressure Change from Baseline in Blood Pressure at 8 weeks of Cardiac Rehabilitation Program Resting systolic and diastolic blood pressure will be measured using a digital automatic blood pressure monitor (Omron Pressmate BP10, Omron Healthcare Co., Ltd, Kyoto, Japan).
Dietary Intake Change from Baseline in Dietary Intake at 8 weeks of Cardiac Rehabilitation Program Dietary intake will be assessed using a 4-day food diary as representative of the usual intake. Patients will be asked to provide detailed information concerning the food and beverages intake for four days (Sunday and 3-week days).
Daily Physical Activity Change from Baseline in Daily Physical Activity at 8 weeks of Cardiac Rehabilitation Program Physical activity will be objectively measured for 7 consecutive days using the ActiGraph accelerometer (model GT1M, Florida, USA).
Biochemical Parameters Change from Baseline in Biochemical Parameters at 8 weeks of Cardiac Rehabilitation Program Fasting plasma glucose, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and HbA1c will be measured by enzymatic methods (912 automatic analyzer, Roche Diagnostic, Basel, Switzerland). Low-density lipoprotein cholesterol will be calculated using the Friedewald equation, except if triglycerides \> 400 mg/dL.
Trial Locations
- Locations (1)
Centro Hospitalar de Vila Nova de Gaia/Espinho
🇵🇹Vila Nova de Gaia, Portugal